The importance of fungal pathogens and antifungal coatings in medical device infections.

In recent years, increasing evidence has been collated on the contributions of fungal species, particularly Candida, to medical device infections. Fungal species can form biofilms by themselves or by participating in polymicrobial biofilms with bacteria. Thus, there is a clear need for effective preventative measures, such as thin coatings that can be applied onto medical devices to stop the attachment, proliferation, and formation of device-associated biofilms. However, fungi being eukaryotes, the challenge is greater than for bacterial infections because antifungal agents are often toxic towards eukaryotic host cells. Whilst there is extensive literature on antibacterial coatings, a far lesser body of literature exists on surfaces or coatings that prevent attachment and biofilm formation on medical devices by fungal pathogens. Here we review strategies for the design and fabrication of medical devices with antifungal surfaces. We also survey the microbiology literature on fundamental mechanisms by which fungi attach and spread on natural and synthetic surfaces. Research in this field requires close collaboration between biomaterials scientists, microbiologists and clinicians; we consider progress in the molecular understanding of fungal recognition of, and attachment to, suitable surfaces, and of ensuing metabolic changes, to be essential for designing rational approaches towards effective antifungal coatings, rather than empirical trial of coatings.

[1]  Pedro J J Alvarez,et al.  Negligible particle-specific antibacterial activity of silver nanoparticles. , 2012, Nano letters.

[2]  M. Ghannoum,et al.  Uses and Limitations of the XTT Assay in Studies of Candida Growth and Metabolism , 2003, Journal of Clinical Microbiology.

[3]  T. Tani,et al.  Antimicrobial activities of iodinated polystyrene derivatives. , 2008, Artificial organs.

[4]  Effects of Precursor and Deposition Conditions on Prevention of Bacterial Biofilm Growth on Chlorinated Plasma Polymers: Effects of precursor and deposition conditions … , 2016 .

[5]  G. Kwon,et al.  Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity. , 2003, Biomacromolecules.

[6]  Henny C van der Mei,et al.  Inhibition of adhesion of yeasts and bacteria by poly(ethylene oxide)-brushes on glass in a parallel plate flow chamber. , 2003, Microbiology.

[7]  B. R. Coad,et al.  Surface coatings with covalently attached caspofungin are effective in eliminating fungal pathogens. , 2015, Journal of materials chemistry. B.

[8]  J. Cerbón,et al.  Generation, modulation and maintenance of the plasma membrane asymmetric phospholipid composition in yeast cells during growth: their relation to surface potential and membrane protein activity. , 1995, Biochimica et biophysica acta.

[9]  J. Beckman,et al.  The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli. , 1995, Archives of biochemistry and biophysics.

[10]  Deborah A. Hogan,et al.  Medically important bacterial–fungal interactions , 2010, Nature Reviews Microbiology.

[11]  David W. Denning,et al.  Hidden Killers: Human Fungal Infections , 2012, Science Translational Medicine.

[12]  B. R. Coad,et al.  Antifungal coatings by caspofungin immobilization onto biomaterials surfaces via a plasma polymer interlayer. , 2015, Biointerphases.

[13]  B. R. Coad,et al.  Biomaterials surfaces capable of resisting fungal attachment and biofilm formation. , 2014, Biotechnology advances.

[14]  Shane J. Stafslien,et al.  Inkjet deposition of itraconazole onto poly(glycolic acid) microneedle arrays. , 2016, Biointerphases.

[15]  D. Andes,et al.  Development and Characterization of an In Vivo Central Venous Catheter Candida albicans Biofilm Model , 2004, Infection and Immunity.

[16]  Niels Bent Larsen,et al.  Studies of spin-coated polymer films , 2005 .

[17]  D. H. Brooks,et al.  Successful salvage of a primary total knee arthroplasty infected with Candida parapsilosis. , 1998, The Journal of arthroplasty.

[18]  C. Fjell,et al.  Screening and characterization of surface-tethered cationic peptides for antimicrobial activity. , 2009, Chemistry & biology.

[19]  Hans J. Griesser,et al.  Antibacterial Surfaces and Coatings Produced by Plasma Techniques , 2011 .

[20]  Jean-Claude Voegel,et al.  Self‐Defensive Biomaterial Coating Against Bacteria and Yeasts: Polysaccharide Multilayer Film with Embedded Antimicrobial Peptide , 2013 .

[21]  H. Sanchez,et al.  Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. , 2010, The Journal of infectious diseases.

[22]  E. Hoek,et al.  A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment , 2010 .

[23]  R. Darouiche,et al.  Antifungal activity of antimicrobial-impregnated devices. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[24]  B. R. Coad,et al.  Plasma polymerization of 1,1,1-trichloroethane yields a coating with robust antibacterial surface properties , 2014 .

[25]  B. R. Coad,et al.  Chlorine-rich plasma polymer coating for the prevention of attachment of pathogenic fungal cells onto materials surfaces , 2016 .

[26]  N. Verstraeten,et al.  Covalent immobilization of antimicrobial agents on titanium prevents Staphylococcus aureus and Candida albicans colonization and biofilm formation. , 2016, The Journal of antimicrobial chemotherapy.

[27]  K. Tománková,et al.  The targeted antibacterial and antifungal properties of magnetic nanocomposite of iron oxide and silver nanoparticles. , 2011, Biomaterials.

[28]  P. Ducheyne,et al.  Covalently Attached Vancomycin Provides a Nanoscale Antibacterial Surface , 2007, Clinical orthopaedics and related research.

[29]  J. Michiels,et al.  Novel anti-infective implant substrates: controlled release of antibiofilm compounds from mesoporous silica-containing macroporous titanium. , 2015, Colloids and surfaces. B, Biointerfaces.

[30]  B. R. Coad,et al.  Caspofungin on ARGET-ATRP grafted PHEMA polymers: Enhancement and selectivity of prevention of attachment of Candida albicans. , 2017, Biointerphases.

[31]  Sean P. Palecek,et al.  Slippery Liquid‐Infused Porous Surfaces that Prevent Microbial Surface Fouling and Kill Non‐Adherent Pathogens in Surrounding Media: A Controlled Release Approach , 2016, Advanced functional materials.

[32]  A. Srinivasan,et al.  From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms. , 2015, Microbiology spectrum.

[33]  Tom Coenye,et al.  Materials with fungi-bioinspired surface for efficient binding and fungi-sensitive release of antifungal agents. , 2014, Biomacromolecules.

[34]  Krasimir Vasilev,et al.  Antibacterial surfaces for biomedical devices , 2009, Expert review of medical devices.

[35]  B. Ha,et al.  How Cell Concentrations Are Implicated in Cell Selectivity of Antimicrobial Peptides. , 2015, Langmuir : the ACS journal of surfaces and colloids.

[36]  M. Aegerter,et al.  Dip Coating Technique , 2004 .

[37]  Wuqaas M. Munir,et al.  Insurgence of Fusarium keratitis associated with contact lens wear. , 2006, Archives of ophthalmology.

[38]  B. Peters,et al.  Polymicrobial Interactions: Impact on Pathogenesis and Human Disease , 2012, Clinical Microbiology Reviews.

[39]  Robert E. W. Hancock,et al.  Multilayered coating on titanium for controlled release of antimicrobial peptides for the prevention of implant-associated infections. , 2013, Biomaterials.

[40]  F. Borgo,et al.  Fungal Biofilms: Update on Resistance. , 2016, Advances in experimental medicine and biology.

[41]  M. Hande,et al.  Cytotoxicity and genotoxicity of silver nanoparticles in human cells. , 2009, ACS nano.

[42]  Kaitlin F. Mitchell,et al.  The Extracellular Matrix of Fungal Biofilms. , 2016, Advances in experimental medicine and biology.

[43]  J. Lopez-Ribot,et al.  Our Current Understanding of Fungal Biofilms , 2009, Critical reviews in microbiology.

[44]  G. Pulverer,et al.  Efficacy of silver-coated medical devices. , 1998, The Journal of hospital infection.

[45]  Carla Renata Arciola,et al.  A review of the biomaterials technologies for infection-resistant surfaces. , 2013, Biomaterials.

[46]  G. Baillie,et al.  Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. , 2002, Journal of medical microbiology.

[47]  B. R. Coad,et al.  Nitric oxide releasing plasma polymer coating with bacteriostatic properties and no cytotoxic side effects. , 2015, Chemical communications.

[48]  Jong Min Lee,et al.  Progress and challenges in control of chemical processes. , 2014, Annual review of chemical and biomolecular engineering.

[49]  P. R. Gardner,et al.  Inducible Defense Mechanism against Nitric Oxide in Candida albicans , 2004, Eukaryotic Cell.

[50]  H. Busscher,et al.  The use of positively charged or low surface free energy coatings versus polymer brushes in controlling biofilm formation , 2006 .

[51]  Adnan Nasir,et al.  Polyglycolic acid microneedles modified with inkjet-deposited antifungal coatings. , 2015, Biointerphases.

[52]  C. Pradier,et al.  Elaboration of antibiofilm surfaces functionalized with antifungal-cyclodextrin inclusion complexes. , 2012, FEMS immunology and medical microbiology.

[53]  Robert Langer,et al.  Antifungal hydrogels , 2007, Proceedings of the National Academy of Sciences.

[54]  H. Hassan,et al.  Candida albicans keratitis in an immunocompromised patient , 2010, Clinical ophthalmology.

[55]  M. Ghannoum,et al.  Modification of Surface Properties of Biomaterials Influences the Ability of Candida albicans To Form Biofilms , 2005, Applied and Environmental Microbiology.

[56]  A. Carrillo-Muñoz,et al.  Biofilm formation by five species of Candida on three clinical materials. , 2011, Journal of microbiological methods.

[57]  I. Hay,et al.  Searching for new strategies against polymicrobial biofilm infections: guanylated polymethacrylates kill mixed fungal/bacterial biofilms. , 2016, The Journal of antimicrobial chemotherapy.

[58]  H. C. van der Mei,et al.  Comparison of methods to evaluate bacterial contact-killing materials. , 2017, Acta biomaterialia.

[59]  C. Edmiston,et al.  Fungal Biofilm Formation on Cochlear Implant Hardware After Antibiotic-Induced Fungal Overgrowth Within the Middle Ear , 2004, The Pediatric infectious disease journal.

[60]  R. Rajendran,et al.  Aspergillus Biofilms in Human Disease. , 2016, Advances in experimental medicine and biology.

[61]  R. Barrack,et al.  Microbiological, clinical, and surgical features of fungal prosthetic joint infections: a multi-institutional experience. , 2009, The Journal of bone and joint surgery. American volume.

[62]  R. Darouiche,et al.  In-vitro activity and in-vivo efficacy of catheters impregnated with chloroxylenol and thymol against uropathogens. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[63]  C. Nobile,et al.  Candida albicans biofilms: development, regulation, and molecular mechanisms. , 2016, Microbes and infection.

[64]  Christophe Egles,et al.  Antifungal coating by biofunctionalized polyelectrolyte multilayered films. , 2005, Biomaterials.

[65]  J. Lai,et al.  Efficacy of selective laser trabeculoplasty for normal tension glaucoma: 1 year results , 2015, BMC Ophthalmology.

[66]  J. V. von Fraunhofer,et al.  Wear characteristics of high-strength denture teeth. , 1988, The Journal of prosthetic dentistry.

[67]  H B Reisman,et al.  Problems in scale-up of biotechnology production processes. , 1993, Critical reviews in biotechnology.

[68]  Sean P. Palecek,et al.  Polyelectrolyte multilayers fabricated from antifungal β-peptides: design of surfaces that exhibit antifungal activity against Candida albicans. , 2010, Biomacromolecules.

[69]  N. Roehm,et al.  An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. , 1991, Journal of immunological methods.

[70]  A. Hidrón,et al.  Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007 , 2008, Infection Control & Hospital Epidemiology.

[71]  M. Ghannoum,et al.  In vitro growth and analysis of Candida biofilms , 2008, Nature Protocols.

[72]  S. Kurtz,et al.  Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. , 2007, The Journal of bone and joint surgery. American volume.

[73]  M. Harriott,et al.  Candida albicans and Staphylococcus aureus Form Polymicrobial Biofilms: Effects on Antimicrobial Resistance , 2009, Antimicrobial Agents and Chemotherapy.

[74]  M. Ghannoum,et al.  Updates on Therapeutic Strategies Against Candida (and Aspergillus) Biofilm Related Infections. , 2016, Advances in experimental medicine and biology.

[75]  M. Stölzel,et al.  Surface analysis of titanium based biomaterials , 1998 .

[76]  Carla Renata Arciola,et al.  Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. , 2010, Biomaterials.

[77]  Optimizing Microplate Biofilm Assays to Screen Anti-infective Surfaces. , 2017, Trends in biotechnology.

[78]  J. Lopez-Ribot,et al.  Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis. , 2009, The Journal of antimicrobial chemotherapy.

[79]  B. Gibbins,et al.  Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. , 2008, The Journal of antimicrobial chemotherapy.

[80]  B. R. Coad,et al.  Facile single-step bioconjugation of the antifungal agent caspofungin onto material surfaces via an epoxide plasma polymer interlayer , 2017 .

[81]  Yuyu Sun,et al.  Antimicrobial Activity and Biocompatibility of Polyurethane—Iodine Complexes: , 2010 .

[82]  M. Ghannoum,et al.  Rabbit Model of Candida albicans Biofilm Infection: Liposomal Amphotericin B Antifungal Lock Therapy , 2004, Antimicrobial Agents and Chemotherapy.

[83]  R. Darouiche,et al.  Antimicrobial activity of antiseptic-coated orthopaedic devices. , 1998, International journal of antimicrobial agents.

[84]  L. Unsworth,et al.  Surface analysis methods for characterizing polymeric biomaterials , 2002, Journal of biomaterials science. Polymer edition.

[85]  J. Friedman,et al.  Demonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter model. , 2010, The Journal of infectious diseases.

[86]  B. R. Coad,et al.  Anti-infective Surface Coatings: Design and Therapeutic Promise against Device-Associated Infections , 2016, PLoS pathogens.

[87]  J. Beuth,et al.  The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activity. , 2000, The Journal of antimicrobial chemotherapy.

[88]  R. Darouiche,et al.  Candida Infections of Medical Devices , 2004, Clinical Microbiology Reviews.

[89]  C. Marra,et al.  Infections of the central nervous system. , 1991, Advances in internal medicine.

[90]  Amanda C. Engler,et al.  Emerging trends in macromolecular antimicrobials to fight multi-drug-resistant infections , 2012 .

[91]  Sean P. Palecek,et al.  Polymer multilayers loaded with antifungal β-peptides kill planktonic Candida albicans and reduce formation of fungal biofilms on the surfaces of flexible catheter tubes. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[92]  Jue Zhang,et al.  Inactivation of Candida Biofilms by Non-Thermal Plasma and Its Enhancement for Fungistatic Effect of Antifungal Drugs , 2012, PloS one.

[93]  Noel Southall,et al.  Rapid Identification of Antifungal Compounds against Exserohilum rostratum Using High Throughput Drug Repurposing Screens , 2013, PloS one.

[94]  B. Fries,et al.  A murine model for catheter-associated candiduria. , 2011, Journal of medical microbiology.

[95]  D. Brabazon,et al.  Silver nanoparticles and their orthopaedic applications. , 2015, The bone & joint journal.

[96]  C. M. Li,et al.  A polycationic antimicrobial and biocompatible hydrogel with microbe membrane suctioning ability. , 2011, Nature materials.

[97]  W. Crielaard,et al.  The effect of Streptococcus mutans and Candida glabrata on Candida albicans biofilms formed on different surfaces. , 2008, Archives of oral biology.

[98]  H. Nelis,et al.  Prevention of Candida albicans Biofilm Formation by Covalently Bound Dimethylaminoethylmethacrylate and Polyethylenimine , 2010, Mycopathologia.

[99]  Melissa M. Reynolds,et al.  Critical nitric oxide concentration for Pseudomonas aeruginosa biofilm reduction on polyurethane substrates. , 2016, Biointerphases.

[100]  L. Lai,et al.  Cladosporium keratitis – a case report and literature review , 2015, BMC Ophthalmology.

[101]  D. M. Lynn,et al.  Antifungal activity of a β-peptide in synthetic urine media: Toward materials-based approaches to reducing catheter-associated urinary tract fungal infections. , 2016, Acta biomaterialia.

[102]  M Brandt,et al.  Toxicity of concentrated sodium hypochlorite used as an endodontic irrigant. , 2004, International endodontic journal.

[103]  H. Griesser,et al.  Small scale reactor for plasma processing of moving substrate web , 1989 .

[104]  S. Tuli,et al.  Fungal Keratitis: Emerging Trends and Treatment Outcomes , 2006, Eye & contact lens.

[105]  Prof. Th. Leber Keratomycosis aspergillina als Ursache von Hypopyonkeratitis , 1879, Albrecht von Graefes Archiv für Ophthalmologie.

[106]  M. R̆ic̆icová,et al.  Candida albicans biofilm formation in a new in vivo rat model. , 2010, Microbiology.

[107]  M. Ghannoum,et al.  Fusarium and Candida albicans Biofilms on Soft Contact Lenses: Model Development, Influence of Lens Type, and Susceptibility to Lens Care Solutions , 2007, Antimicrobial Agents and Chemotherapy.

[108]  D. Andes,et al.  Beta -1,3 glucan as a test for central venous catheter biofilm infection. , 2007, The Journal of infectious diseases.

[109]  N. Read,et al.  Understanding the mechanism of action of cell-penetrating antifungal peptides using the rationally designed hexapeptide PAF26 as a model , 2013 .

[110]  A. Michelmore,et al.  Variability in Plasma Polymerization Processes – An International Round‐Robin Study , 2013 .

[111]  P. Kingshott,et al.  Surface modification and chemical surface analysis of biomaterials. , 2011, Current opinion in chemical biology.

[112]  K. Hirota,et al.  Effect of substrate surface hydrophobicity on the adherence of yeast and hyphal Candida , 2010, Mycoses.

[113]  Peng Li,et al.  Antimicrobial functionalization of silicone surfaces with engineered short peptides having broad spectrum antimicrobial and salt-resistant properties. , 2014, Acta biomaterialia.

[114]  Philipp Stiefel,et al.  In Vitro Biofilm Models for Device-Related Infections. , 2016, Trends in biotechnology.

[115]  H. Sanchez,et al.  Interface of Candida albicans Biofilm Matrix-Associated Drug Resistance and Cell Wall Integrity Regulation , 2011, Eukaryotic Cell.

[116]  J. Latgé,et al.  The Fungal Cell Wall: Structure, Biosynthesis, and Function , 2017, Microbiology spectrum.

[117]  D. Soll,et al.  Plasticity of Candida albicans Biofilms , 2016, Microbiology and Molecular Reviews.

[118]  D. Kontoyiannis,et al.  Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance. , 2011, The Journal of infectious diseases.

[119]  M. Schoenfisch,et al.  Efficacy of surface-generated nitric oxide against Candida albicans adhesion and biofilm formation , 2010, Biofouling.

[120]  J. Nett Future directions for anti-biofilm therapeutics targeting Candida , 2014, Expert review of anti-infective therapy.

[121]  E. Veerman,et al.  A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides , 1999, FEBS letters.

[122]  M. Landers,et al.  Ultrathin coating by plasma polymerization applied to corneal contact lens. , 1975, Journal of biomedical materials research.

[123]  A. A. Cury,et al.  In vitro Candida colonization on acrylic resins and denture liners: influence of surface free energy, roughness, saliva, and adhering bacteria. , 2007, The International journal of prosthodontics.

[124]  M. Kim,et al.  Risk factors for and clinical implications of mixed Candida/bacterial bloodstream infections , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[125]  A. A. Del Bel Cury,et al.  Efficacy of denture cleansers on Candida spp. biofilm formed on polyamide and polymethyl methacrylate resins. , 2011, The Journal of prosthetic dentistry.

[126]  P. Devaux,et al.  Static and dynamic lipid asymmetry in cell membranes. , 1991, Biochemistry.

[127]  Tom Coenye,et al.  In vitro and in vivo model systems to study microbial biofilm formation. , 2010, Journal of microbiological methods.

[128]  Gordon Ramage,et al.  Candida biofilms on implanted biomaterials: a clinically significant problem. , 2006, FEMS yeast research.

[129]  D. Marriott,et al.  Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp. , 2008, Critical care medicine.

[130]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[131]  J. Costerton,et al.  Biofilms as complex differentiated communities. , 2002, Annual review of microbiology.

[132]  N. Read,et al.  Concentration‐dependent mechanisms of cell penetration and killing by the de novo designed antifungal hexapeptide PAF26 , 2012, Molecular microbiology.

[133]  A. Telenti,et al.  Polymicrobial fungemia: microbiology, clinical features, and significance. , 1989, Reviews of infectious diseases.

[134]  L. Ferreira,et al.  Antifungal activity of dental resins containing amphotericin B-conjugated nanoparticles. , 2013, Dental materials : official publication of the Academy of Dental Materials.